MUC1 and cancer: To explore the in vitro cancer targeting of the Apt-NPs against the MUC1-overexpressing cells, we compared the cellular uptake of MCF-7 (MUC1+) and HepG2 (MUC1−) using FCM analysis (Fig. 5).